Register
Login:
Share:
Email Facebook Twitter


London South East Natural Resources Briefing webcast: #Emmerson #Alba #Condor Gold #Gold analysis
Angus Energy in talks to buy 'transformational' gas asset in North England


Glaxosmithkline Share News (GSK)

Stock Market news at lse.co.uk - RSS News Feeds

Share News for Glaxosmithkline (GSK)


Share Price: 1,582.00Bid: 1,581.20Ask: 1,581.60Change: 0.00 (0.00%)No Movement on Glaxosmithkline
Spread: 0.40Spread as %: 0.03%Open: 1,577.60High: 1,586.80Low: 1,570.60Yesterday’s Close: 1,582.00




BRIEF-GlaxoSmithKline makes submission to U.S. FDA for diabetes drug

Mon, 14th Jan 2013 10:18

LONDON, Jan 14 (Reuters) - GlaxoSmithKline Plc:

* GSK submits albiglu
tide bla to the US FDA

* Intends to submit a regulatory application in the European union (EU) in

early 2013

* Albiglutide is not yet approved as a treatment for type 2 diabetes or any

other indication

((London Equities Newsroom; +44 20 7542 7717))



(For more news, please click here)

COPYRIGHT
Copyright Thomson Reuters 2013. All rights reserved.
The copying, republication or redistribution of Reuters News Content, including by framing or similar means, is expressly prohibited without the prior written consent of Thomson Reuters.






UPDATE 1-GSK brings back bonuses for some sales reps

(Adds background on bribery scandals and fines)May 23 (Reuters) - British drugmaker GlaxoSmithKline said on Thursday it will reintroduce incentive pay
[23 May '19 18:07]

GSK to change incentives for sales representatives

May 23 (Reuters) - British drugmaker GlaxoSmithKline said on Thursday it will change incentives for sales representatives in some countries as it look
[23 May '19 15:21]

UPDATE 1-Amgen to buy Copenhagen-based Nuevolution for $167 mln

(Adds detail, background, shares)May 22 (Reuters) - Amgen, the world's largest biotechnology company, agreed on Wednesday to buy Scandinavian biopharm
[22 May '19 09:54]

UPDATE 2-Brexit worries hit domestic stocks but sterling slide lifts FTSE 100

* FTSE 100 up 0.1%, FTSE 250 down 0.7%* Exporters top boost to main index* Brexit-sensitive stocks slip* M&S slumps after discounted offering* IG gain
[22 May '19 09:33]

Trade rhetoric weighs on European shares

(For a live blog on European stocks, type LIVE/ in an Eikon news window)May 17 (Reuters) - European shares dropped on Friday after three days of gains
[17 May '19 08:03]

Ex-divs to take 23.6 points off FTSE 100 on May 16

MILAN, May 13 (Reuters) - The following FTSE 100 companies will go ex-dividend on Thursday, after which investors will no longer qualify for the lates
[13 May '19 09:55]

UK regulator investigates China's state broadcaster for airing TV confession

LONDON, May 8 (Reuters) - Britain's broadcasting watchdog has launched a formal investigation into whether a confession made by a British man and aire
[8 May '19 15:14]

UK's Vectura wins patent infringement case against GlaxoSmithKline in U.S.

May 4 (Reuters) - British drugmaker Vectura Group Plc said on Saturday that it won a patent infringement litigation case against GlaxoSmithKline Plc i
[4 May '19 17:24]



Share Price, Share Chat, Stock Market news at lse.co.uk
FREE Member Services
- Setup a personalised Watchlist and Virtual Portfolio.
- Gain access to LIVE real-time Regulatory News (RNS).
- View more Trades, Directors' Deals, and Broker Ratings.
Share Price, Share Chat, Stock Market news at lse.co.uk






Datafeed and UK data supplied by NBTrader and Digital Look. While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk.
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.